Date: 2021-05-26
Time:
1730- 1900 UTC
1030-1200 PDT
Zoom Meeting Details
Topic: SNOMED Editorial Advisory Group Conference Call
Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/99997961770?pwd=TWRiclpVeTU3RG1kUE1lTWNkVFBCZz09
Password: 287392
Meeting ID: 999 9796 1770
International numbers available: https://snomed.zoom.us/u/abTbQn2e26
Or Skype for Business (Lync):
https://snomed.zoom.us/skype/99997961770
Observers:
Apologies:
Meeting Files:
Meeting minutes:
The call recording is located here.
Objectives
- Obtain consensus on agenda items
Discussion items
Item | Description | Owner | Notes | Action |
---|---|---|---|---|
1 | Call to order and role call | Start recording! | ||
2 | Conflicts of interest and agenda review | No conflicts noted | ||
5 | Concept inactivation workgroup update | Inactivation of Ambiguous Concepts - examples and updated proposal Document attached to the agenda Meeting Files above. Discussion: Decision: |
| |
6 | Specimen hierarchy term change proposal | Jim Case | Inquiries from Germany outlined inconsistencies in terming in the Specimen hierarchy. A background document with proposed changes is available for review and comment by the EAG prior to broader circulation: Discussion: Group generally felt that historically and clinically, specimen and sample were used interchangeably. There was unanimous agreement on the changing of FSNs and PTs to use the term "specimen". James R. Campbellobjected to the universal addition of "sample" descriptions to terms that already had "Specimen" in their FSNs Update 6/14/2021: From UNMC via Jim Campbell: "I asked Scott to poll our anatomic pathologists (and also lab pathologists) whether Specimen and Sample can be considered synonyms. The answer was clearly NO. Anatomic pathology is arguably the clearest example where the surgical Tissue Specimen is examined visually by the pathologist who then dissects the tissue into component Samples representing important aspects of the case Specimen. The samples are processed in Blocks for histologic examination and results are reported with reference to the Sample Block. In this way examination of Margins, lymphatic invasion, regional invasion and spread of the malignancy can be assessed and reported. " Note: Additional clarification on the James R. Campbell proposed solution was sought. From the LIVD Community via John Snyder: "I brought this up to the LIVD team for discussion as it includes members from LOINC, APHL, Abbott laboratories, and FDA. In general, everyone agreed that the two terms are used synonymously across the implementation level and are in favor of the work listed under Next Steps section being completed. While they did recognize that there were some edge cases where differentiation between the two may be useful, at this time the group did not think the edge cases were significant enough to out-weigh the general benefit." Decision: EAG consensus was that changes to FSNs may be made without inactivation and replacement of concepts. |
|
7 | ECE Topics | Bruce Goldberg | Pressure injury | |
8 | Next meeting | EAG |
| |